Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pox viral vaccine approaches.

Philip M Arlen1, Howard L Kaufman, Robert S DiPaola

  • 1Laboratory of Tumor Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Seminars in Oncology
|December 13, 2005
PubMed
Summary

Viral vectors show promise for cancer vaccines by mimicking infection to boost immunity. Poxviral vaccines targeting prostate-specific antigen (PSA) and carcinoembryonic antigen (CEA) are discussed as examples.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local immunotherapy for the treatment of cancer: scientific advances and clinical potential.

Journal for immunotherapy of cancer·2026
Same author

IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancer.

Frontiers in immunology·2026
Same author

Temporal molecular remodeling of T cells informs their possible adaptation in 4T1 tumors.

Computational and structural biotechnology journal·2026
Same author

Targeting Tumor-Draining Lymph Nodes to Improve the Therapeutic Potential of Oncolytic Viruses.

Cancer immunology research·2026
Same author

Locally Advanced Conjunctival Squamous Cell Carcinoma not Responsive to Immune Checkpoint Inhibitor Therapy: 3 Cases and a Literature Review.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Letter to the EditorTumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy.

Neuro-oncology·2025

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Advances in tumor-specific immunity fuel excitement for cancer vaccines.
  • Understanding immunologic principles enables enhanced tumor immunity via vaccination.
  • Various immunotherapy approaches exist, including peptides, proteins, dendritic cells, antibodies, DNA, tumor cells, and viral vectors.

Purpose of the Study:

  • This review focuses on viral vectors for cancer immunotherapy.
  • Viral vectors offer advantages for gene delivery and adjuvant activity in vaccination.
  • The review examines poxviral vaccines targeting prostate-specific antigen (PSA) and carcinoembryonic antigen (CEA) as models.

Main Methods:

  • Review of preclinical and clinical development of viral vector-based cancer vaccines.
  • Focus on poxvirus family (replicating and nonreplicating) for expressing tumor antigens and immunomodulatory genes.
  • Discussion of specific examples: prostate-specific antigen (PSA) and carcinoembryonic antigen (CEA) poxviral vaccines.

Main Results:

  • Viral vectors mimic natural infection, inducing potent immune responses.
  • Poxviruses are effective for expressing tumor antigens and immunomodulatory genes (cytokines, costimulatory molecules).
  • Preclinical and clinical data support the potential of poxviral vaccines for cancer treatment.

Conclusions:

  • Viral vectors are attractive for cancer immunotherapy due to their ability to induce strong immune responses.
  • Poxviral vaccines targeting specific tumor antigens like PSA and CEA represent a promising therapeutic strategy.
  • Further development of viral vector-based vaccines holds significant potential for cancer treatment.

Related Experiment Videos